Stay updated on Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A new Revision: v3.5.4 tag was added and older items including Melanoma, related topics, MedlinePlus Genetics, and Revision: v3.5.3 were removed, indicating a small site-wide update rather than changes to the trial content.
    Difference
    0.1%
    Check dated 2026-05-18T04:01:09.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The Taiwan location label was updated from 'Taoyuan District, Taiwan, 333' to 'Taoyuan, Taiwan, 333' in the Locations list, preserving the same postal code and reflecting a standardized city name.
    Difference
    0.0%
    Check dated 2026-05-03T19:34:42.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Updated the “related topics”/glossary area to reflect the sponsor name branding (“Ono Pharmaceutical Co., Ltd.”) and added the associated “Revision: v3.5.3” site version marker, replacing the previous “Revision: v3.5.0” and slightly different formatting.
    Difference
    0.1%
    Check dated 2026-04-26T15:42:56.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The term 'Melanoma' and the MedlinePlus Genetics related topic reference are removed from the page, diminishing visibility of the study's focus and its related resources.
    Difference
    0.1%
    Check dated 2026-04-12T11:48:32.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Location entry updated from Padua, Italy to Padova, Italy to reflect local naming.
    Difference
    0.0%
    Check dated 2026-04-05T07:36:28.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Added Melanoma as a related topic and MedlinePlus Genetics as a related topic. These additions enhance discoverability and contextual navigation without altering the core study details.
    Difference
    0.1%
    Check dated 2026-03-29T05:27:00.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page.